<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00904878</url>
  </required_header>
  <id_info>
    <org_study_id>CCFA Pregnancy Registry</org_study_id>
    <secondary_id>CCFA pregnancy Registry</secondary_id>
    <nct_id>NCT00904878</nct_id>
  </id_info>
  <brief_title>A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease</brief_title>
  <official_title>A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Crohn's and Colitis Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with
      Inflammatory Bowel Disease study is being conducted at the University of California San
      Francisco and 30 other sites around the United States who are part of the CCFA Clinical
      Alliance. The aim of this study is to determine the effect of medication use and disease
      activity on the outcome of pregnancy among women with IBD up to 4 years from birth.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All pregnant women with IBD diagnosis who are taking biologics medicines and
      immunosuppressants will be entered in the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determine whether children born to women with IBD have higher rates of developmental delay compared to their age matched non-IBD peers, as measured by the Ages and Stages Questionnaire (ASQ-3) at ages 12, 24, 36, and 48 months</measure>
    <time_frame>December 2014</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine whether the rate of any adverse pregnancy outcomes in a prospective national sample of women from the United States with IBD differ with respect to exposure to azathioprine/6MP or anti-TNF therapy</measure>
    <time_frame>December 2014</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Determine whether breastfeeding impacts developmental delay, growth and infectious complications in children born to women with IBD</measure>
    <time_frame>December 2014</time_frame>
  </other_outcome>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Inflammatory Bowel Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients with confirmed IBD diagnoses who are pregnant
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients with confirmed IBD diagnoses who are pregnant and taking
             immunosuppressants and/or biologic therapy

        Exclusion Criteria:

          -  Pregnant female patients younger than 18 years of age

          -  Confirmed multiple gestation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Uma Mahadevan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yelena Idomsky</last_name>
    <phone>415-353-7871</phone>
    <email>yelena.idomsky@ucsfmedctr.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Please Contact Natalia Wagner For Further Information Regarding Other Sites' Locations</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Wagner</last_name>
      <phone>415-885-3734</phone>
      <email>natalia.wagner@ucsf.edu</email>
    </contact>
    <investigator>
      <last_name>Uma Mahadevan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2009</study_first_submitted>
  <study_first_submitted_qc>May 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2009</study_first_posted>
  <last_update_submitted>January 4, 2016</last_update_submitted>
  <last_update_submitted_qc>January 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnant IBD patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

